Evogene's Sales, Loss Rise in Q1 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Evogene today reported that its first-quarter revenues increased nearly 13 year over year, and its loss nearly tripled from the same period a year ago.

The Rehovot, Israel-based firm reported total revenues of $2.7 million for the three-month period ended March 31, 2010, compared to $2.4 million for the first quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.